Omega Therapeutics, Inc.

The momentum for this stock is not very good. Omega Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Omega Therapeutics, Inc..

News

Q3 2024 EPS Estimates for Omega Therapeutics, Inc. (NASDAQ:OMGA) Increased by HC Wainwright

Zolmax Omega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Research analysts at HC Wainwright upped their Q3 2024 earnings per share (EPS) estimates for Omega Therapeutics in a research report issued...\n more…

HC Wainwright Comments on Omega Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:OMGA)

Ticker Report Omega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Stock analysts at HC Wainwright increased their Q3 2024 earnings estimates for Omega Therapeutics in a research note issued to investors on...\n more…

Omega Therapeutics appoints Nelson as SVP of Research

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research

Globe Newswire CAMBRIDGE, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ( Omega ), a biotechnology company pioneering the development of a new class of programmable epigenomic...\n more…

FY2024 EPS Estimates for Omega Therapeutics, Inc. (NASDAQ:OMGA) Raised by Chardan Capital

Ticker Report Omega Therapeutics, Inc. (NASDAQ:OMGA - Free Report) - Research analysts at Chardan Capital upped their FY2024 earnings per share estimates for Omega Therapeutics in a research note issued on...\n more…

Omega Therapeutics (NASDAQ:OMGA) PT Lowered to $6.00 at Chardan Capital

Ticker Report Omega Therapeutics (NASDAQ:OMGA - Free Report) had its target price decreased by Chardan Capital from $7.00 to $6.00 in a report released on Wednesday morning, Benzinga reports. Chardan Capital...\n more…